Rapamycin Nanotherapy for Type 1 diabetes

This is a promising targeted rapamycin therapy when combined with pancreatic islet transplant:

Using these rapamycin-loaded nanocarriers, the researchers generated a new form of immunosuppression capable of targeting specific cells related to the transplant without suppressing wider immune responses.

1 Like